Annual report pursuant to Section 13 and 15(d)

ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.0.1
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 21, 2020
Mar. 23, 2020
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Research and development costs     $ 566,655 $ 1,198,780 $ 633,050
Impairment loss       25,320,555 25,320,555
Deferred tax asset       4,129,000 2,830,000
Advertising and marketing costs       $ 104,738 $ 96,637
Valuation allowance, percentage       100.00% 100.00%
Ownership interest, percentage     1.38% 1.38% 1.38%
Common stock, shares authorized     100,000,000 100,000,000 100,000,000
Common stock, par value     $ 0.00001 $ 0.00001 $ 0.00001
Loss from operation       $ (5,555,234) $ (28,269,589)
Annual Meeting of Shareholders [Member]          
Common stock, shares authorized   100,000,000 800,000,000 800,000,000  
Common stock, par value   $ 0.00001 $ 0.00001 $ 0.00001  
Description of reverse stock split The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders      
Property, Plant and Equipment [Member]          
Loss from operation     $ (39,434) $ (25,320,555) $ (25,359,989)